Please login to the form below
Axon
This page shows the latest Axon news and features for those working in and with pharma, biotech and healthcare.
Avenir Global moves four UK agencies into new office space in London
AXON, Cherry, Hanover and Madano will now be based in London’s Bankside area. ... It will house four of Avenir's leading UK brands – AXON, Cherry, Hanover and Madano.
Latest news
-
Lilly buys biotech firm Disarm Therapeutics for $135m
the loss of axons – the long cable of nerve cells that send out electrical impulses.
-
AXON recognised for ‘excellence in wellbeing’ by Great Place to Work
Healthcare communications company AXON has been recognised by Great Place to Work for 'Excellence in Wellbeing' for the second consecutive year. ... The ‘Excellence in Wellbeing’ award is the latest AXON has received in a series of awards from Great
-
Avenir Global acquires UK communications firm Hanover
Avenir was already represented within the region with AXON Communications, which has office bases in London, Copenhagen, Zug, Brighton, New York and Toronto.
-
Lilly partners with AC Immune on tau drug for Alzheimer’s
Other companies working on tau include Eisai/Biogen who are looking at combining a tau blocker with an anti-amyloid drug, as well as Bristol-Myers Squibb, Axon Neuroscience and Astellas.
-
Avenir acquires Cherry, EY wins new account and GK unites businesses
In recent years, Axon has expanded it services to New York, Copenhagen, and Brighton, and has a client roster spanning the pharma and med-tech industries. ... At the same time, we see exciting synergies with AXON to expand the services we offer clients.
Lilly buys biotech firm Disarm Therapeutics for $135m
AXON recognised for ‘excellence in wellbeing’ by Great Place to Work
Avenir Global acquires UK communications firm Hanover
Lilly partners with AC Immune on tau drug for Alzheimer’s
Avenir acquires Cherry, EY wins new account and GK unites businesses
More from news
Approximately 2 fully matching, plus 25 partially matching documents found.
Latest Intelligence
-
The far-reaching impact of the COVID-19 pandemic on clinical trials
AXON Communications and Hanover Communications are part of AVENIR GLOBAL, a powerhouse firm of specialist healthcare communications agencies.
-
Behaviour change: what is the buzz all about?
By Gareth Morrell, Head of Insights, Madano and Emma Kenny, Partner, AXON Communications – both part of the AVENIR GLOBAL group of companies.
-
Lessons from a squirrel
Miranda Dini, AXON managing partner and executive committee member, Healthcare Communications Association.
-
Why does the global data warehouse approach not work?
DI was founded by ex-IMS International colleagues Mike Askew and Jon Axon to address the un-met need to cohesively manage pharma clients' disparate sales and marketing data. ... Jon Axon, Chief Architect Data Intelligence. Jon co-founded Data
-
The evolving landscape of medical education
And that can only be a good thing.” – Miranda Dini, managing partner, Axon Communications. ... She can be contacted at snataraja@axon-com.com.
The far-reaching impact of the COVID-19 pandemic on clinical trials
Behaviour change: what is the buzz all about?
Lessons from a squirrel
Why does the global data warehouse approach not work?
The evolving landscape of medical education
More from intelligence
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest appointments
-
New faces at HCA, P\S\L Group and Health Unlimited
Choi is currently chief operating officer of McCann Health Medical Communications, while Kenny is currently a partner and operations director at AXON Communications.
-
AVENIR GLOBAL appoints global healthcare lead
Dini has been leading the AXON business, part of the AVENIR network, in Europe since 2012. ... While at the specialist healthcare communications company, Dini oversaw a significant growth of the operations, and helped to establish AXON as a leading
-
Makara Health bolsters team with six new hires
She joins from KISS communications, and has previously worked at InterComm, AXON Communications and AS&K Mercury Healthcare Communications.
-
Healthcare Comms appointments
Martello, who was director of medical communications agency AXON Communications, will be responsible for the direction, management and growth of IMC’s UK office.
-
Weekly comms appointments
Axon promotes team members. Hello and welcome to the weekly round-up of communications appointments. ... AXON, a medical communications group, has strengthened its agency offerings with two internal promotions.
New faces at HCA, P\S\L Group and Health Unlimited
AVENIR GLOBAL appoints global healthcare lead
Makara Health bolsters team with six new hires
Healthcare Comms appointments
Weekly comms appointments
More from appointments
Approximately 10 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Innovative approaches in the treatment of multiple sclerosis
Nerve function is dependent on the ability of electrical signals to flow through the wire-like axons of neurons, which are wrapped in and insulated by myelin sheaths.
-
Innovative approaches in the treatment of multiple sclerosis
Nerve function is dependent on the ability of electrical signals to flow through the wire-like axons of neurons, which are wrapped in and insulated by myelin sheaths.
-
Three key development areas in the management of multiple sclerosis
axons degenerate, NfL are released into the blood or cerebrospinal fluid.
-
AXON Communications
AXON, a global healthcare consulting firm, harnesses the diverse expertise of our talented team to help our clients create science-based strategies and drive stakeholder activation. ... AXON serves the healthcare communications needs of clients in the
AXON Communications
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
CEO, Head of Health, UK
-
Six figure salary
-
Omnichannel Strategy Consultant
-
Competitive Salary
-
CEO Pricing & Market Access, UK
-
Six figure salary
-
Senior Account Manager
-
Competitive salary offered
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Valneva COVID-19 vaccine more effective than AZ
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- US demand for COVID-19 antibody treatments rising fast
- Call for industry innovators to join working group
- Pfizer-BioNTech booster offers 95.6% efficacy against COVID-19
- US COVID-19 booster programme expanded
- The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
- Mind the Gap – Challenging Immunisation Apathy and Misinformation
- Towards Better HCP Engagement – An Email Masterclass
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Valneva COVID-19 vaccine more effective than AZ
- Beyond yoga and smoothies – providing real support for employee well-being
- The Future of eHealth: Contactless Health Monitoring
- NICE looks internally for new chief executive
PMHub
certain health
Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...
Latest intelligence
- The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
- The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
- Mind the Gap – Challenging Immunisation Apathy and Misinformation
- world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
- Towards Better HCP Engagement – An Email Masterclass
- 6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....
